Delivery Order SPE2DB20D1004-SPE2DB25FNGSK
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $1,638.00 and is a firm fixed-price contract with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to reduce the risk of stroke and blood clots. The contract has a ceiling value of $1,474.20 and a period of performance through April 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $9,728.67 and a period of performance through April 2025. It is a firm fixed-price contract, which means the price will not change regardless of the contractor's costs. The contract is not set aside...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a total ceiling value of $3,931.20 and a period of performance ending on April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a firm fixed price and a ceiling value of $23,182.59. It is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of April 29, 2025 and was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $9,019.05 and a period of performance through April 29, 2025. It is a firm-fixed-price contract, indicating a set price for the delivered items. The contract is not set-aside and was awarded through open...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $31,835.29 and a period of performance ending on April 28, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablet 60s, a medication used to treat and prevent blood clots. The contract has a ceiling value of $10,603.32 and is a firm fixed-price contract with an ultimate completion date of April 29, 2025. This award is not a set-aside contract, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $1,965.60 and a period of performance through April 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with AmerisourceBergen valued at $999,999,999.00, which provides...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a prescription medication used to treat and prevent certain types of blood clots. The contract has a ceiling value of $2,319.04 and is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp holds a larger...